Moody's Investors Service has affirmed Chambersburg, Pa.-based Summit Health's "A2" rating, affecting approximately $119.3 million of outstanding debt.
The rating affirmation is based on Summit's strong operating results and leading market position.
Summit Health also faces challenges, including service area competition, pressured volumes and the upcoming implementation of a new EHR.
The outlook is stable, reflecting Moody's Investors Service's expectation that Summit will continue to generate solid operating results.